pharmaceuticals

Pharmacies were once routinely bequeathed from one generation to the next, but, in interviews with more than a dozen pharmacists,...

A partnership between a telehealth company specializing in mental healthcare and a biotech company will use remote patient monitoring to...

An Urban Institute analysis found that The Build Back Better Act's drug inflation rebate provision would reduce premiums by $3...

As overdose deaths nationwide reach all-time highs, the Biden administration has made increasing access to naloxone a key part of...

Experts say the success of the treatments would hinge on one uncertain factor: whether high-risk patients infected with covid will...

Congress created the 340B program in 1992 to provide extra funding for hospitals and clinics, especially those serving the poor...

Independent pharmacies are struggling due to the vertical integration among drugstore chains, insurance companies and pharmaceutical benefit managers, which gives...

If beneficiaries decide to use traditional Medicare when they first join the program, they can pick a private supplemental plan...

The DEA is exacerbating the opioid epidemic by scaring pharmacies away from dispensing this medication when it's desperately needed.

Who should decide which patients qualify for treatment: dementia specialists or primary care physicians?

The U.S. has been slower to adopt biosimilar drugs since the first such medicine was approved in 2015.